LONDON (Alliance News) - Verona Pharma PLC said Friday that it has taken on a secondary listing on the Xetra exchange, part of Deutsche Borse, in Germany.
The drug development company said it has opted to list on the Xetra to raise its profile in continental Europe, and to increase the potential for investors in Germany-speaking Europe to trade in its shares.
Shares in Verona are trading up 10% at 6.75 pence Friday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.